TRNAU1AP

Across TCGA pan-cancer cohorts, TRNAU1AP mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TRNAU1AP’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where TRNAU1AP mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TRNAU1AP is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

LUAD, CCRCC, and LSCC are the cancer types where TRNAU1AP tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRNAU1AP mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.146	<.001	7	view →
CCRCC	Male	All	+0.170	<.001	6	view →
LSCC	Male	All	+0.149	<.001	5	view →
OV	All	All	+0.456	.032	2	view →
PDAC	All	III,IV	−0.291	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TRNAU1AP–LUAD

Open the LUAD breakdown →